b57 peptide B57 is a split antigen from the B17 broad antigen - HLAb57abacavir HLA-B*57:01 peptides Unraveling the Significance of the B57 Peptide in Immune Response

HLAB57ankylosing spondylitis The b57 peptide is a crucial element within the complex landscape of the human immune system, primarily associated with the HLA-B57 gene. This gene belongs to the Human Leukocyte Antigen (HLA) system, which plays a vital role in distinguishing self from non-self, a fundamental process for immune surveillance作者：GM O'Connor·2015·被引用次数：102—Two suchpeptidesfacilitated productive interactions between HLA-B*57:01 and KIR3DS1. These data reveal the presence of KIR3DS1 ligands within the HIV-specific .... Understanding the b57 peptide and its interactions offers profound insights into immune responses, particularly in the context of viral infections like HIV.

HLA-B57 is a specific serotype within the broader B17 antigen family, with B58 being its sister serotype. This genetic allele is recognized for its association with effective control of viral infections. Specifically, HLA-B57 is claimed to protect people from HIV, with individuals possessing this allele often exhibiting slower disease progression and a better prognosis compared to those without it. This protective effect is largely attributed to the ability of HLA-B57 to present a wide array of peptides to immune cells.作者：GM O'Connor·2015·被引用次数：102—Two suchpeptidesfacilitated productive interactions between HLA-B*57:01 and KIR3DS1. These data reveal the presence of KIR3DS1 ligands within the HIV-specific ...

The b57 peptide itself, or rather the peptides presented by the HLA-B57 molecule, are central to this protective mechanismHLA–B*57:01. In stock. 0.00. Serological Name: B57. Peptide Load: Endogenous. Size: 30.0 µg. Modification: Unmodified. Volume: 30.0 µl. Conjugate: .... Research indicates that HLA-B57 has a broad peptide-binding specificity, enabling it to bind and present a diverse range of viral fragments, including highly conserved Gag-derived HIV peptides. This broad presentation capability is thought to limit the possibility of viral escape, a common challenge in combating rapidly mutating viruses like HIV. The HLA-B57 allele has been shown to be associated with long-term asymptomatic HIV-1 infection, underscoring its significant role in immune control.

Further detailed investigation into specific HLA-B*57:01 (a common variant of HLA-B57) reveals intricate mechanisms of immune cell recognition. For instance, studies have shown that certain peptides, such as the KF11 peptide, can stabilize the HLA-B57-peptide complex more effectively than others, like the KI8 peptide作者：KJ Laing·2022·被引用次数：1—HLA-B*57:01is an HLA allelic variant associated with positive outcomes during viral infections through interactions with T cells and NK cells.. This stabilization is critical for the efficient presentation of viral antigens to T cells. The HLA-B*57:01 allele, in particular, is associated with positive outcomes during viral infections through its interactions with both T cells and natural killer (NK) cells.

The precise molecular interactions involving the b57 peptide and immune receptors are areas of active research. For example, the interaction between HLA-B*57:01 and the KIR3DS1 receptor has been investigated, with specific peptides facilitating productive interactions. These data highlight the presence of KIR3DS1 ligands within HIV-specific contexts.Biotinylated Human Peptide Ready HLA-B*57:01&B2M ... Moreover, research into HLA-B57 micropolymorphism demonstrates how subtle variations within the HLA-B57 molecule can influence peptide antigen presentation by closely related HLA molecules like HLA-B*57:01 and HLA-B*57:03HLA-B*57:01 Complexed to a CD8 T-Cell Epitope from the .... This micropolymorphism can shape allele-specific responses and impact the stimulation of antigen-specific T cells.

The clinical implications of HLA-B57 extend beyond HIV. Associations with conditions such as behçet disease and ankylosing spondylitis have been explored, although the exact mechanisms are still under investigation. The presence of B-HLA-B57.1 in specific mouse models provides valuable tools for preclinical research into HLA-B57 related immune responses.B-HLA-B57.1 mice - Gene Humanized Mouse Models

In summary, the b57 peptide, as presented by the HLA-B57 molecule, is a critical player in immune defense, particularly against viral pathogens like HIV. Its broad peptide-binding specificity and the intricate interactions it facilitates with T cells and NK cells contribute significantly to viral control.HLA–B*57:01, B5701 Ongoing research continues to unravel the complexities of these interactions, offering potential avenues for therapeutic interventions and a deeper understanding of human immunity. The study of HLA-B*57:01 and its associated peptides is an active field, contributing to our knowledge of how this genetic component influences disease outcomes and immune responses.